Prevalence, Clinical Features, Neuroimaging, and Genetic Findings in Children With Ataxic Cerebral Palsy in Europe

Veronka Horber1, Guro L Andersen1, Catherine Arnaud1

  • 1From the Department of Paediatric Neurology (V.H., I.K.-M.), University Children's Hospital Tübingen, Germany; Norwegian Quality and Surveillance Registry for Cerebral Palsy (G.L.A.), Vestfold Hospital Trust, Tønsberg, Norway; CERPOP (C.A.), UMR 1295 Toulouse University, Inserm, Paul Sabatier University, Toulouse; Clinical Epidemiology Unit (C.A.), University Hospital of Toulouse, France; Imas12 (J.D.L.C.), Hospital Universitario 12 de Octubre, RedSAMID, Madrid Spain; Department of Pediatrics (I.D.), Children's Hospital, University of Zagreb Croatia; Association Rehabilitation Center (A.G.), Riga, Latvia; The Central Remedial Clinic (O.H.), Dublin, Ireland; Department of Pediatrics (K. Himmelmann), Clinical Sciences, Sahlgrenska Academy, University of Gothenburg; Regional Rehabilitation Centre (K. Himmelmann), Queen Silvia Children's Hospital, Gothenburg, Sweden; Department of Pediatrics (K. Hollody), Faculty of Medicine, University of Pecs, Hungary; Childhood Disability and Development (K. Horridge), University of Sunderland, UK; Zentrum für Kinderneurologie (C.T.K.), Entwicklung und Rehabilitation, Ostschweizer Kinderspital, St. Gallen, Switzerland; Developmental Age Mental Health and Rehabilitation Unit (M.M.), ASL (local Health Institution Viterbo), Viterbo, Italy; Department of Development and Regeneration (E.O.), KU Leuven, Belgium; Iaso Children's Hospital (A.P.), Athens, Greece; Queen's University Belfast (O.P.), UK; Norwich Medical School (M.J.P.), University of East Anglia, Norwich, UK; Department of Pediatrics and Adolescent Medicine (G.R.), Aarhus University Hospital, Denmark; Counselling and Diagnostic Centre (S.S.), Iceland Department of Child and Adolescent & Developmental Neurology (A.T.G.), Children´s Hospital, University Medical Centre Ljubljana, Slovenia; PVNPC (D.V.), Programa de Vigilância Nacional da Paralisia Cerebral, Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal; Grenoble Alpes University (E.S.), CNRS, Grenoble INP, CHU Grenoble Alpes, TIMC-IMAG; and Registre des Handicaps de l'Enfant et Observatoire Périnatal (E.S.), Grenoble, France.

Neurology
|October 19, 2023
PubMed

Insights

Ataxic cerebral palsy (CP) affects 3.8% of children, often presenting with severe intellectual impairment rather than gross motor deficits. Genetic factors are frequently implicated, necessitating thorough genetic evaluation alongside neuroimaging.

Area of Science:

  • Neurology
  • Pediatrics
  • Developmental Pediatrics

Background:

  • Ataxic cerebral palsy (CP) is a rare subtype of CP.
  • Understanding its prevalence, characteristics, and origins is crucial for diagnosis and management.

Purpose of the Study:

  • To determine the prevalence of ataxic CP.
  • To analyze associated impairments, severity, and neuroimaging findings in children with ataxic CP.
  • To explore potential etiological factors.

Main Methods:

  • Analysis of data from 20 European CP registers (1980-2010).
  • Inclusion of 679 children diagnosed with ataxic CP.
  • Assessment of birth characteristics, impairments, neuroimaging, and syndromes using validated SCPE guidelines.

Main Results:

  • Ataxic CP accounted for 3.8% of cases, with significant regional variation.
  • Approximately 70% could walk, but 40% had severe intellectual impairment.
  • Most children were born at term with normal birth weight; neuroimaging showed diverse findings, with brain maldevelopments and normal findings being most common.
  • Genetic syndromes were identified in 9% of cases.

Conclusions:

  • Ataxic CP presents a distinct profile with more pronounced cognitive than motor dysfunction.
  • The condition is often associated with term birth and rarely suggests acquired injuries.
  • Diagnosis remains challenging, and a comprehensive genetic workup is recommended in addition to neuroimaging.
Abstract

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
14